Reska Biotech

Reska Biotech FCF Margin

The Free Cash Flow Margin of Reska Biotech (GWIN) as of Oct 12, 2026 is 51.12 %. In the previous year, Free Cash Flow Margin was 51.12 % — a change of 0.00% (higher).

FCF Margin

51.12 %

YoY

0.00%

Last updated:

Free Cash Flow Margin of Reska Biotech is 2022 51.12 % . Free Cash Flow Margin of Reska Biotech was 2021 51.12 % . It decreases by 0.00% higher compared to the previous year.

The Reska Biotech FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2015
73.74 USD
Jan 1, 2016
51.12 USD
Jan 1, 2022
51.12 USD
The Reska Biotech FCF Margin history
YEARFCF MarginYoY
51.12 %+0.00%
51.12 %-30.68%
73.74 %—
Access this data via the Eulerpool API

Reska Biotech Stock analysis

What does Reska Biotech do? The Glorywin Entertainment Group Inc is a Hong Kong-based company that specializes in the production, management, and marketing of entertainment content. The company was founded in 2005 and has been listed on the Canadian stock exchange since 2015. Glorywin's business model is based on the production and marketing of entertainment content in various sectors. This includes film and television production, music labels, event management, as well as the management and marketing of artists and celebrities. Over the years, the company has developed and produced a variety of products. In the film and television sector, these include TV series such as "The Four Detective Guards," "Journey to the East," "Ten Deadly Sins," and "Saviors in the Forbidden City." In addition, Glorywin has also produced films for the cinema such as "The Four," "Kung Fu Angels," and "The White Storm." Musically, the company is primarily active in the Asian pop industry and operates its own label with well-known artists such as Coco Lee and Janice Vidal. Another important business area for Glorywin is event management. The company organizes concerts, festivals, and other events in China and other Asian countries. The most well-known events include the "MTV Super Summit," the "Pepsi Music Festival," and the "Hong Kong Asian-Pop Music Festival." Glorywin often collaborates with other companies to reach a wider audience. In addition to the production of entertainment content and event management, Glorywin also operates its own leisure facilities. The goal is to make the brand and products of the company accessible to a broader audience. The company primarily focuses on theme parks and interactive museums. Currently, Glorywin operates the "Three Kingdoms City" theme park in China and the "Cool & Ice World" museum in Hong Kong. In recent years, the company has also focused on the digital media sector. Glorywin operates its own social media platform for fans and has developed a chatbot system for interactive communication with customers. The goal is to position and market the brand and products even more strongly in the digital world. To coordinate and manage all these activities, Glorywin has built an experienced team of managers and producers. The company works closely with international partners and collaborators to develop innovative products and events that excite the audience and tap into new markets. Overall, the company has become an important player in the Asian entertainment industry in recent years and has achieved numerous successes. This success is supported by the increasing popularity of Asian pop music, TV series, and films worldwide. In the future, Glorywin will likely continue to focus on these trends and attempt to establish itself in new markets. Reska Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Reska Biotech stock

Free Cash Flow Margin of Reska Biotech is 51.12 % in 2022.

Free Cash Flow Margin of Reska Biotech changed from 51.12 % to 51.12 %, representing a 0.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Reska Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Reska Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Reska Biotech

All Key Metrics — Reska Biotech